This paper provides an overview of various demand- and supply-side controls used to set pharmaceutical prices. Then, a supply-side measure used in the United Kingdom, the Pharmaceutical Price Regulation Scheme (PPRS), is reviewed. The industry's view of the scheme, its domestic policy context, and the transplantability of the PPRS to the United States are covered.
